Can Rosemary Defeat Super‑Resistant Bacteria?

A research team tested hydroalcoholic rosemary extract (RHE) against a tough foe: the mixed biofilm of Candida albicans and multidrug‑resistant bacteria such as Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa. After extracting compounds with alcohol and water, they measured flavonoids and phenols, finding an EC50 of 19.5 µg/mL, indicating strong antioxidant activity. Using HPLC‑DAD and GC‑MS they identified rosmarinic acid and α‑pinene, two molecules known for antimicrobial properties.

MIC and MMC tests showed RHE is microbicidal and can cut biofilm formation by up to 70 % in vitro, even outperforming 0.12 % chlorhexidine. Biofilms act like a protective “coat” that makes microbes harder to kill; breaking them is key to fighting resistant infections.

These findings suggest that rosemary, a common kitchen herb, could become a basis for new drugs or disinfectants against pathogens that no longer respond to traditional antibiotics. Of course, the experiments are still in the lab, but they open the door to greener, less synthetic‑chemical therapies.

The chemical analysis of Rosmarinus officinalis extract revealed a rich composition of phenolic compounds, notably rosmarinic acid (≈ 2.3 mg/g of extract) and flavonoids such as luteolin and apigenin. These phytochemicals exhibit antioxidant activity by donating electrons to the DPPH radical, with an EC50 of 19.53 µg/mL, indicating the ability to neutralize about 50 % of free radicals at concentrations below 20 µg/mL.

MIC (Minimum Inhibitory Concentration) tests showed values between 125‑250 µg/mL for the tested bacteria, while MMC (Minimum Microbicidal Concentration) was 2‑4 times higher, suggesting a bacteriostatic effect at low concentrations and bactericidal at higher doses. Antibiofilm activity was assessed with the MTT assay, which measures metabolic reduction of cells within the biofilm. RHE reduced the viability of the mixed C. albicans‑A. baumannii biofilm by 69.6 % (p < 0.05), outperforming 0.12 % chlorhexidine (≈55 % reduction).

The likely mechanism involves destabilization of the extracellular matrix of the biofilm, particularly degradation of polysaccharides and structural proteins, due to rosmarinic acid interacting with glucose chains and α‑pinene acting as a lipophilic agent that compromises bacterial membranes. Additionally, monoterpene terpenes (e.g., cineole) may interfere with quorum‑sensing signaling, reducing microbial coordination of biofilm formation.

These findings support the concept that plant extracts, when standardized and combined with nanocarrier technologies (e.g., liposomes or silver nanoparticles), can enhance penetration and stability of active principles, paving the way for topical or systemic formulations to treat chronic resistant infections. Nonetheless, further in‑vivo studies, systemic toxicity assessments, and pharmacokinetic profiling are required before clinical translation.